Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
1.505
-0.045 (-2.90%)
At close: Mar 27, 2026, 4:00 PM EDT
1.470
-0.035 (-2.33%)
After-hours: Mar 27, 2026, 7:58 PM EDT
Cyclerion Therapeutics Employees
Cyclerion Therapeutics had 1 employees as of September 30, 2025. The number of employees did not change compared to the same quarter last year.
Employees
1
Change
n/a
Growth
n/a
Revenue / Employee
$2,855,000
Profits / Employee
-$2,199,000
Market Cap
5.73M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 1 | 0 | - |
| Jun 30, 2025 | 1 | 0 | - |
| Mar 31, 2025 | 1 | 0 | - |
| Dec 31, 2024 | 1 | 0 | - |
| Sep 30, 2024 | 1 | 0 | - |
| Jun 30, 2024 | 1 | - | - |
| Mar 31, 2024 | 1 | -15 | -93.75% |
| Dec 31, 2023 | 1 | -15 | -93.75% |
| Dec 31, 2022 | 16 | -16 | -50.00% |
| Dec 31, 2021 | 32 | -2 | -5.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| NuCana | 22 |
| Cardio Diagnostics Holdings | 17 |
| Processa Pharmaceuticals | 10 |
| MetaVia | 9 |
| Ernexa Therapeutics | 7 |
| Immuron | 7 |
| Xenetic Biosciences | 2 |
| SciSparc | 2 |
CYCN News
- 5 weeks ago - Cyclerion Therapeutics Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board - GlobeNewsWire
- 2 months ago - Cyclerion Therapeutics Announces Strategic Agreement with Medsteer and Progress Toward Initiating Phase 2 Proof-of-Concept Study for CYC-126 in Treatment-Resistant Depression - GlobeNewsWire
- 6 months ago - Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company - GlobeNewsWire
- 1 year ago - Cyclerion's sGC Stimulator Portfolio Generates Revenues to Enable Company Growth - GlobeNewsWire
- 1 year ago - Regina Graul, Ph.D., Promoted to Chief Executive Officer - GlobeNewsWire
- 2 years ago - Cyclerion Appoints Regina Graul, Ph.D., as President - GlobeNewsWire
- 2 years ago - Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator - GlobeNewsWire
- 2 years ago - Tisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion Assets - GlobeNewsWire